scispace - formally typeset
F

Faye E. Mendelson

Researcher at University of Michigan

Publications -  17
Citations -  210

Faye E. Mendelson is an academic researcher from University of Michigan. The author has contributed to research in topics: Prediabetes & Medicine. The author has an hindex of 4, co-authored 11 publications receiving 73 citations.

Papers
More filters
Journal ArticleDOI

The Divergent Roles of Dietary Saturated and Monounsaturated Fatty Acids on Nerve Function in Murine Models of Obesity.

TL;DR: It is reported that dietary intervention with monounsaturated fatty acids reverses the progression of neuropathy and restores nerve function in high-fat diet-fed murine models of peripheral neuropathy.
Journal ArticleDOI

Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes.

TL;DR: Mouse models of prediabetes and type 2 diabetes that develop peripheral neuropathy display increased levels of nerve triglycerides, which return to normal upon dietary reversal, suggesting that altered lipids are involved in disease.
Journal ArticleDOI

Juvenile murine models of prediabetes and type 2 diabetes develop neuropathy

TL;DR: The mouse models described in this paper provide critical tools to better understand the underlying pathogenesis of prediabetic and diabetic neuropathy from youth to adulthood, and support the idea that hyperglycemia alone does not drive early neuropathy.
Journal ArticleDOI

NK cells associate with ALS in a sex- and age-dependent manner

TL;DR: In this article, the authors investigated whether NK cells impact ALS in a sex- and age-specific manner and found that NK cell depletion extended survival in female but not male ALS mice with sex-specific effects on spinal cord microglia.
Journal ArticleDOI

Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes.

TL;DR: The effect of empagliflozin (EMPA), an inhibitor of the sodium/glucose cotransporter 2 (SGLT2), on diabetic neuropathy (DPN), retinopathy (DR), and kidney disease (DKD) in streptozotocin-induced T1D and db/db T2D mouse models is studied.